PHASE-I-II STUDY OF RADIOLABELED ANTIBODY INTEGRATED IN THE TREATMENT OF PRIMARY HEPATIC MALIGNANCIES

被引:95
作者
ORDER, SE
KLEIN, JL
ETTINGER, D
ALDERSON, P
SIEGELMAN, S
LEICHNER, P
机构
[1] JOHNS HOPKINS MED INST,DEPT RADIAT ONCOL,BALTIMORE,MD 21205
[2] JOHNS HOPKINS MED INST,DEPT MED ONCOL & IMMUNOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS MED INST,DEPT NUCL MED,BALTIMORE,MD 21205
[4] JOHNS HOPKINS MED INST,DEPT RADIOL SCI,BALTIMORE,MD 21205
[5] JOHNS HOPKINS MED INST,DEPT RADIAT PHYS,BALTIMORE,MD 21205
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1980年 / 6卷 / 06期
关键词
D O I
10.1016/0360-3016(80)90226-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:703 / 710
页数:8
相关论文
共 29 条
[1]   LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY [J].
BOLTON, AE ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1973, 133 (03) :529-538
[2]  
BROWNELL GL, 1968, J NUC MED S1, P28
[3]  
DILLMAN LT, 1975, MED INT RAD DOS MIRD, P5
[4]  
ESHHAR T, 1974, P NATL ACAD SCI USA, V81, P3956
[5]  
ETTINGER DS, 1979, CANCER TREAT REP, V63, P131
[6]  
FALKSON G, 1978, CANCER, V42, P2149, DOI 10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO
[7]  
2-5
[8]  
FRIEDMAN M, 1979, CANCER-AM CANCER SOC, V44, P906, DOI 10.1002/1097-0142(197909)44:3<906::AID-CNCR2820440318>3.0.CO
[9]  
2-9
[10]   DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES [J].
GOLD, P ;
FREEDMAN, SO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (03) :439-+